Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
William S. Reardon currently holds 1,946 shares of SYNTA PHARMACEUTICALS CORP (SNTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William S. Reardon has been a net buyer of SNTA stock. They have purchased $161.1K and sold $0 worth of shares.
William S. Reardon's most recent insider trade was on Apr 6, 2021, when they sold 486 shares at $14.26 per share.
William S. Reardon serves as Executive at SYNTA PHARMACEUTICALS CORP (SNTA). They have executed 34 insider transactions totaling $161.1K over their tenure at the company.
William S. Reardon holds the position of Executive at SYNTA PHARMACEUTICALS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
William S. Reardon has shown a buying trading pattern, with $161.1K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by William S. Reardon was on Nov 13, 2013, when they purchased $50.0K worth of SNTA shares. This transaction involved 13,333 shares at $3.75 per share.
William S. Reardon currently owns 1,946 shares of SYNTA PHARMACEUTICALS CORP (SNTA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of William S. Reardon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. William S. Reardon has 34 Form 4 filings on record as an insider at SYNTA PHARMACEUTICALS CORP.
Set alerts for William S. Reardon and 40,000+ other insiders.